Search

everythinglearnresearchcommunity

for

Search:↓

Long-term baricitinib treatment can lead to significant scalp hair regrowth in patients initially showing only eyebrow or eyelash regrowth.

Chronic T. gondii infection may harm male fertility.

Ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata.

Cytokeratin 19 and cytokeratin 15 are key markers for monitoring the quality and self-renewing potential of engineered skin.

Tofacitinib helped over half of the patients with severe hair loss regrow at least 50% of their hair.

Targeting METTL1 may help slow papillary thyroid cancer growth and spread.

Baricitinib is a safe and effective alternative for alopecia areata patients who do not respond to tofacitinib.

Mutations in the KLHL24 gene cause skin blistering in epidermolysis bullosa simplex.

Tet2 and Tet3 enzymes are important for controlling hair growth and shape by affecting gene activity and DNA structure in hair follicles.

Newborns with the common rash Erythema Toxicum have many active mast cells in their skin, but these cells don't produce the LL-37 peptide.

JAK inhibitors help regrow hair in alopecia areata, but their long-term safety is still unclear.

Erlotinib can cause hair loss as a side effect.

Continuous treatment with ritlecitinib and brepocitinib is needed to maintain hair regrowth in alopecia areata.

The assay effectively identifies compounds that affect immune cell activation.

Tofacitinib, a medication for arthritis, showed potential for treating severe hair loss in a small Brazilian case series, but more research is needed.

AVT is highly conserved and may have antimicrobial properties.

Biological therapy boosts the immune system to effectively fight melanoma.

Two drugs, ritlecitinib and brepocitinib, improved scalp hair loss condition markers.

Melatonin helps hair grow by activating a specific signaling pathway.

Combined BRAF and MEK treatment increases rash risk but reduces other skin issues compared to BRAF alone.

Ruxolitinib significantly improves multiple autoimmune conditions in APS-1 patients.

Rituximab effectively treated a woman's bone lymphoma that was resistant to other treatments.

The LTF gene may help predict and manage nonspecific orbital inflammation.

Forsythiaside A reduces kidney damage from sepsis by lowering inflammation and cell death.

A balance between BMP and Wnt signals is crucial for hair follicle stem cell function and hair growth.

Biotinidase deficiency can be easily diagnosed and treated with biotin to prevent serious harm.

Melatonin reduces BMP2 gene expression in goat hair follicles during the resting period.

Permanent hair loss after bone marrow transplant can be caused by chemotherapy or chronic graft-versus-host disease.

Microneedle therapy combined with Hwangryeonhaedoktang solution improved hair growth in mice better than microneedle therapy alone.